Join Alaina and Zarmeen this week as they celebrate Zarmeen's birthday by diving into the recently published report of a phase 2 clinical trial of psilocybin for treatment resistant depression. They go over some background, methodology and results surrounding the study and what it means moving forward. Of course, they also give their interpretations and discuss thoughts about sensationalism, limitations and the things they liked about the study. CW: suicidal ideation and self-injury.The content of YBOS is the opinion of the authors and does not reflect the opinion of others or author affiliations.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-08-2025 12AM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 11PM EST
08 Dec 2025
NPR News Now
NPR News: 12-07-2025 10PM EST
08 Dec 2025
NPR News Now
Meidas Health: AAP President Strongly Pushes Back on Hepatitis B Vaccine Changes
08 Dec 2025
The MeidasTouch Podcast
Democrat Bobby Cole Discusses Race for Texas Governor
07 Dec 2025
The MeidasTouch Podcast